Hyperferritinemia in a woman with systemic lupus erythematosus, severe nephritis and an iron-rich intraspinal schwannoma mimicking lupus myelopathy

Clinical and Experimental Rheumatology

Volumn 27, Issue 5, 2009, Pages 834-837

  Conca, W ^a   Al Hakim, M ^b   Moussa, N ^c   Al Salam, S ^a   Corr, P ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c AL AIN HOSPITAL   (United Arab Emirates)

Author keywords

Ferritins; Lupus nephritis; Mycophenolate mofetil; Neurilemmoma; Spinal cord diseases

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; IRON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPERFERRITINEMIA; INTRASPINAL SCHWANNOMA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; NEURILEMOMA; PANCYTOPENIA; PRIORITY JOURNAL; PROTEINURIA; SPINAL CORD COMPRESSION; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; CERVICAL VERTEBRAE; FEMALE; FERRITINS; HUMANS; LUPUS NEPHRITIS; MIDDLE AGED; MYCOPHENOLIC ACID; NEURILEMMOMA; PREDNISONE; SPINAL CORD NEOPLASMS;

EID: 72949114443     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. EMMENEGGER U, SCHAER DJ, LARROCHE C, NEFTEL KA: Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135: 299-314.
2. MOSCA M, BOMBARDIERI S: Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol 2007; 25 (Suppl. 47): S107-13.
3. NISHIYA K, HASHIMOTO K: Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15: 39-44.
4. LIM MK, LEE CK, JU YS et al.: Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001; 20: 89-93. (Pubitemid 32250118)
5. BEYAN E, BEYAN C, DEMIREZER A, ERTUGRUL E, UZUNER A: The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 2003; 32: 225-228
6. HESSELINK DA, AARDEN LA, SWAAK AJG: Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol 2003; 32: 151-155
7. WALSH M, JAMES M, JAYNE D, TONELLI M, MANNS BJ, HEMMELGARN BR: Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2007; 2: 968-975
8. ISHII T, ONDA H, TANIGAWA A et al.: Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Research 2005; 12: 429-439 (Pubitemid 43843812)
9. STAM TC, SWAAK AJG, KRUIT WHJ, EGGERMONT AMM: Regulation of ferritin: a specific role for interferon-alpha (IFN-α)? The acute phase response in patients treated with IFN-α-2b. Eur J Clin Invest 2002; 32 (Suppl. 1): 79-83.
10. TILG H, ULMER H, KASER A, WEISS G: Role of IL-10 for induction of anemia during inflammation. J Immunol 2002; 169: 2204-2209
11. SU DL, WANG HJ, JI XH et al.: Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Acta Pharmacol Sin 2006; 27: 1051-1057
12. BRANTEN AJW, SWINKELS DW, KLASEN IS, WETZELS JFM: Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol Dial Transplant 2004; 19: 2754-2760
13. KULAKSIZ H, THEILIG F, BACHMANN S et al.: The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005; 184: 361-370
14. PITASHNY M, SCHWARTZ N, QING X et al.: Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 2007; 56: 1894-1903
15. PARK CK, KIM DC, PARK SH et al.: Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas. J Neurosurg 2006; 105: 576-580
16. FINELLI PF, NAIK K, DIGIUSEPPE JA, PRASAD A: Primary lymphoma of CNS, mycophenolate mofetil and lupus. Lupus 2006; 15: 886-888